Therefore, this series indicates that it is not possible to determine the lower Tg limit for an indication of TSH-stimulated contrast-enhanced 18F-FDG PET/CT in patients with suspicion of recurrence of differentiated thyroid carcinoma. This evidence concerns the gene TG and differentiated thyroid carcinoma.